Vaxart Inc. 2015 - Jul 2019
Associate Director, Clinical Immunology
Focus Diagnostics Quest Diagnostics Now Q2 Solutions 2004 - 2014
Manager, Research and Development
Clarient Feb 2003 - May 2004
Scientist, Assay Discovery
University of New Mexico 2001 - 2003
Post-Doctoral Fellow, Department of Pathology
Unilever 1993 - 1996
Senior Research Biologist, Phytochemistry
Education:
Uc Irvine 1996 - 2001
Doctorates, Doctor of Philosophy, Virology
The Johns Hopkins University 1989 - 1993
Bachelors, Bachelor of Arts, Biology, Chemistry
Kinkaid School 1982 - 1989
Skills:
Cell Based Assays Clinical Trials Vaccines Elisa Infectious Diseases Cell Culture Life Sciences Diagnostics Clinical Development Immunology Validation Science Pharmaceuticals Virology R&D Research Immunoassays Tissue Culture Cancer Fda Immunohistochemistry Biopharmaceuticals Medical Diagnostics Laboratory Pharmaceutical Industry Lifesciences Sop Cell Laboratory Skills
Feb 2014 to 2000 Manager, Medical WritingFOCUS DIAGNOSTICS, INC Cypress, CA 2004 to Feb 2014 Manager, Research and DevelopmentCHROMAVISION MEDICAL SYSTEMS, INC San Juan Capistrano, CA 2003 to 2004 Scientist, Assay DiscoveryUNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE Albuquerque, NM 2001 to 2003 Post-Doctoral Fellow, Department of PathologyUNIVERSITY OF CALIFORNIA Irvine, CA 1996 to 2001 Graduate Student, Department of Molecular Biology and BiochemistryUNILEVER RESEARCH Edgewater, NJ 1993 to 1996 Senior Research Biologist, Phytochemistry
Education:
UNIVERSITY OF CALIFORNIA Irvine, CA 1996 to 2001 Ph.D. in Biological SciencesTHE JOHNS HOPKINS UNIVERSITY Baltimore, MD 1989 to 1993 BA in Chemistry/Biology
Us Patents
Method Of Quantitating Proteins And Genes In Cells Using A Combination Of Immunohistochemistry And In Situ Hybridization
Kenneth Bauer - San Clemente CA, US Keith Gottlieb - Newport Beach CA, US Scott Webster - Mission Viejo CA, US
International Classification:
G06F 19/00
US Classification:
702019000
Abstract:
The disclosure provides a system for and method of accurately determining the status of a protein target and a nucleic acid target in a biological sample (e.g., a tissue or cell sample). Provided are methods of quantitating a protein target and a nucleic acid target in a tissue or cell sample using image analysis to correlate the optical density of a chromogenic stain to the concentration of a target molecule in a biological sample. The use CISH in combination with IHC to accurately determine the status of two independent target molecules is provided. A computer-aided image analysis system is used to process and analyze optical images of a chromagen-stained tissue or cell sample and to determine the optical density of the stained tissue or cell sample.